Lilly drug slows Alzheimer’s decline in large study

An experimental drug developed by Eli Lilly significantly slowed mental and physical decline in a large clinical trial of people with early Alzheimer’s disease, the company said Wednesday in a result that brings closer a new treatment for the most common cause of dementia.